Fludeoxyglucose F 18 Injection
Product Images NDC 52670-551

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F 18 (NDC 52670-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayo Clinic, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fludeoxyglucose F 18 Injection Usp Is Provided As A Ready To Use Sterile, Pyrogen Free, Clear, Colorless Citrate Buffered Solution. Each mL Contains Between 0.740 To 8.88 Gbq (20.0­240 Mci) Of 2-deoxy-2-[18f]fluoro-d-glucose At The Eos, 4.5 mg Of Sodium Chloride In Citrate Buffer. The Ph Of The Solution Is Between 4.5 And 7.5. The Solution Is Packaged In A Multiple-dose Glass Vial And Does Not Contain Any Preservative. Ethanol (3 mg/ml) Is Used As An Antioxidant In Fludeoxyglucose F 18 Injection Usp. (Fludeoxyglucose F 18 Injection 01)

Fludeoxyglucose F 18 Injection Usp Is Provided As A Ready To Use Sterile, Pyrogen Free, Clear, Colorless Citrate Buffered Solution. Each mL Contains Between 0.740 To 8.88 Gbq (20.0­240 Mci) Of 2-deoxy-2-[18f]fluoro-d-glucose At The Eos, 4.5 mg Of Sodium Chloride In Citrate Buffer. The Ph Of The Solution Is Between 4.5 And 7.5. The Solution Is Packaged In A Multiple-dose Glass Vial And Does Not Contain Any Preservative. Ethanol (3 mg/ml) Is Used As An Antioxidant In Fludeoxyglucose F 18 Injection Usp. (Fludeoxyglucose F 18 Injection 01)
FDA Label Image

Principal Display Panelndc 52670-551-30fludeoxyglucose F 18 Injection, Uspintravenous Userx Only (Fludeoxyglucose F 18 Injection 02)

Principal Display Panelndc 52670-551-30fludeoxyglucose F 18 Injection, Uspintravenous Userx Only (Fludeoxyglucose F 18 Injection 02)
This is a description of a medical product - Fludeoxyglucose F 18 Injection. The product has a National Drug Code (NDC) number of 5267055430 and is meant for intravenous use only. The product comes in a sterile nor-pyrogenic solution, and the production lot number, EOS date, time and volume are all specified. The product has a concentration of mCi per ml, and its expiry date and time are also provided. The product is stored upright at controlled room temperature, with permissible excursions to 17-27°C. The product is manufactured by Mayo Clinic PET radiochemistry facility located at 200 First Street SW, Rochester, MN 55905-0001.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.